These documents require Acrobat Reader (for PDF). You can download the Acrobat Reader for free from the Adobe's download page (www.adobe.com).

 

News

May 04, 2011

Fresenius: Excellent start into 2011 − Fresenius raises 2011 sales and earnings outlook

PDF-Download (156 KBytes)

February 23, 2011

Fresenius: Record results in 2010: All financial targets met or exceeded – Positive outlook for 2011

PDF-Download (165 KBytes)

November 11, 2010

Fresenius Kabi and Boehringer Ingelheim RCV successfully coupled HES to a therapeutic protein in an industrial scale applying Fresenius Kabi’s HESylation® Technology

PDF-Download (23 KBytes)

November 02, 2010

Fresenius reports excellent sales and earnings growth – Raises outlook

PDF-Download (165 KBytes)

August 03, 2010

Fresenius SE: Excellent sales and earnings growth – Earnings outlook raised

PDF-Download (167 KBytes)

July 27, 2010

Fresenius SE: First half of 2010: Preliminary Group net income substantially better than expected − Earnings outlook raised

PDF-Download (35 KBytes)

June 10, 2010

Ketosteril Research Award - Solemn Award Ceremony at the XV International Congress on Nutrition and Metabolism in Renal Disease in Lausanne, Switzerland

PDF-Download (128 KBytes)

May 04, 2010

Fresenius SE: Q1 2010: Successful start into 2010 − Outlook fully confirmed

PDF-Download (142 KBytes)

March 26, 2010

MNI Grant for the Best Initiative to Fight Malnutrition

PDF-Download (27 KBytes)

February 24, 2010

Fresenius SE: Record financial results in 2009 − All financial targets met or exceeded − Positive outlook for 2010

PDF-Download (132 KBytes)

January 27, 2010

Fresenius Group’s initial relief assists over 185,000 Haiti earthquake victims

PDF-Download (29 KBytes)

January 13, 2010

Fresenius Kabi and Bayer Schering Pharma extend collaboration regarding HESylation® Technology

PDF-Download (21 KBytes)

November 03, 2009

Fresenius SE: Q1-3/2009: Strong organic sales growth achieved - Outlook for 2009 fully confirmed

PDF-Download (130 KBytes)

October 28, 2009

Fresenius Kabi and Octapharma Group enter into an Exclusive License, Development and Supply Agreement for a HESylated recombinant protein

PDF-Download (28 KBytes)

August 04, 2009

Fresenius SE: H1 2009: Maintains growth momentum: Confirms outlook

PDF-Download (136 KBytes)

May 18, 2009

Fresenius Kabi and Bayer Schering Pharma enter into a Research, Development and License Agreement regarding HESylation® Technology

PDF-Download (19 KBytes)

April 30, 2009

Fresenius SE: Q1 2009: Successful start into 2009

PDF-Download (164 KBytes)

February 19, 2009

Fresenius SE: Successful 2008 − Financial targets fully met or exceeded − Positive outlook for 2009

PDF-Download (152 KBytes)

November 04, 2008

Fresenius SE: Q1-3/2008: Continued strong growth − Sales outlook raised

PDF-Download (193 KBytes)

September 10, 2008

Fresenius closes APP acquisition

PDF-Download (24 KBytes)

September 02, 2008

Fresenius and APP Pharmaceuticals Announce Clearance of APP Acquisition by U.S. Federal Trade Commission

PDF-Download (24 KBytes)

August 11, 2008

Acquisition of Dabur Pharma successfully closed

PDF-Download (24 KBytes)

July 30, 2008

Fresenius SE: First half 2008 - Strong financial results

PDF-Download (117 KBytes)

July 17, 2008

Strong financial results in the first half of 2008 (preliminary figures)

PDF-Download (29 KBytes)

July 07, 2008

Fresenius Kabi to acquire APP Pharmaceuticals – entry into North American I.V. generics market provides excellent growth opportunities

 click here

June 30, 2008

Ketosteril Research Award - Solemn Award Ceremony at the ICNMRD 2008 in Marseilles, France

PDF-Download (224 KBytes)

April 30, 2008

Fresenius SE: Q1 2008 - Successful start into 2008

PDF-Download (164 KBytes)

April 20, 2008

Fresenius Kabi strengthens its position in i.v. drugs by acquiring Dabur Pharma, a leading manufacturer of oncology generics

PDF-Download (40 KBytes)

February 20, 2008

Fresenius achieves record financial results in 2007 Positive outlook for 2008

PDF-Download (75 KBytes)

December 11, 2007

Fresenius Kabi acquires leading European manufacturer of antibiotic agents and strengthens its position in the area of intravenously administered generic drugs

PDF-Download (27 KBytes)

December 07, 2007

Fresenius Kabi expands infusion therapy business in Latin America

PDF-Download (26 KBytes)

November 26, 2007

Fresenius Kabi continues growth strategy and strengthens its Clinical Nutrition business

PDF-Download (28 KBytes)

October 31, 2007

Fresenius SE - Q1-3 2007: Excellent sales and earnings growth in all business segments – Strong third quarter – Outlook raised

PDF-Download (139 KBytes)

August 02, 2007

Fresenius SE - First half 2007: Fresenius reports continued growth in sales and earnings and raises full-year earnings outlook

PDF-Download (116 KBytes)

May 02, 2007

Fresenius AG - Q1 2007: Successful start to 2007

PDF-Download (75 KBytes)

February 22, 2007

Fresenius AG: Fiscal Year 2006

PDF-Download (87 KBytes)

October 31, 2006

Fresenius AG - First nine months 2006: Excellent sales and earnings growth in all business segments – Strong third quarter – Outlook raised

PDF-Download (108 KBytes)

October 11, 2006

Fresenius plans conversion into European Company (SE) and share split

PDF-Download (35 KBytes)

August 03, 2006

Fresenius AG: First half of 2006

PDF-Download (107 KBytes)

May 03, 2006

Fresenius AG: First quarter 2006

PDF-Download (103 KBytes)

February 22, 2006

Fresenius AG: Fiscal Year 2005

PDF-Download (103 KBytes)

January 03, 2006

Fresenius Kabi raises its stake in Pharmatel Fresenius Kabi Pty Ltd. to 50.1%

PDF-Download (18 KBytes)

November 03, 2005

Fresenius AG: Excellent financial results in the 1st- 3rd quarter of 2005; full year outlook confirmed

PDF-Download (114 KBytes)

November 01, 2005

Peter Fürst Research Prize

DOC-Download (26 KBytes)

October 14, 2005

Fresenius continues profitable growth: Acquisition of Clinico to develop Fresenius Kabi's medical devices business

PDF-Download (108 KBytes)

August 04, 2005

First half of 2005: Fresenius achieves excellent financial results and raises full-year earnings outlook

PDF-Download (118 KBytes)

June 27, 2005

Fresenius Kabi and Pall enter Agreement to Accelerate Adoption of Prion Reduction Technology

PDF-Download (27 KBytes)

May 04, 2005

First Quarter 2005: Excellent start for Fresenius Group into fiscal year 2005

PDF-Download (128 KBytes)

March 17, 2005

Fresenius Kabi recognized by Frost & Sullivan for Competitive Strategy Leadership in Clinical Nutrition

PDF-Download (78 KBytes)

March 16, 2005

Fresenius Kabi closed acquisition of I.V. drug company Labesfal

PDF-Download (43 KBytes)

March 02, 2005

Fresenius Kabi strengenths position in China - increases stake in joint venture from 65% to 100%

PDF-Download (45 KBytes)

February 24, 2005

Excellent business performance in 2004; Positive outlook for 2005

PDF-Download (125 KBytes)

January 07, 2005

Fresenius Kabi continues growth strategy and acquires I.V. drug company

PDF-Download (51 KBytes)

December 08, 2004

Fresenius Kabi: Market leader builds on success

PDF-Download (55 KBytes)

December 07, 2004

Fresenius Kabi strengenths position in central and eastern europe

PDF-Download (40 KBytes)

September 06, 2004

Fresenius Kabi is expanding its market presence in Australia

PDF-Download (44 KBytes)